Genome sequencing studies of human AML samples have identified a significant association between initiating mutations (e.g., NPM1, PML::RARA) and the development of downstream cooperating mutations in RTK/RAS signaling genes. The gene discussed is PML; the disease is acute myeloid leukemia.